Back to search

Switzerland· 67010001

Emtricitabin/Tenofovir Viatris, Filmtabletten

A tenofovir disoproxil and emtricitabine product, registered in Switzerland by Viatris Pharma GmbH and dispensed under Swissmedic category A. The same ATC class is registered in 13 of our 19 countries.

Cat A (Swissmedic)ATC J05AR03

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedEmtricitabin/Tenofovir Viatris, Filmt…ATCJ05AR03REGISTER NO.67010001PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Tenofovir disoproxil and emtricitabine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR03 (tenofovir disoproxil and emtricitabine), each read from that country’s own register.

  • This record: Switzerland
  • 8 of them publish a price we can compare per daily dose

Tenofovir disoproxil and emtricitabine · ATC J05AR03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Viatris Pharma GmbH
Country
Switzerland (CH)
ATC code
J05AR03
ATC class
Tenofovir disoproxil and emtricitabine
Swissmedic category
A
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

9 interactions on record for tenofovir disoproxil and emtricitabine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tenofovir disoproxil and emtricitabine · interactions on record

9 records

9 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c44a4f5d-78c1-4c4f-8230-36b68fff701f
GET /v1/drugs/c44a4f5d-78c1-4c4f-8230-36b68fff701f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}

See everything about tenofovir disoproxil and emtricitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.